Skip to main content

BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle

New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep

LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) — via IBN — More than 1 in 3 American adults report insufficient sleep — a deficit that research increasingly links to measurable declines in next-day cognitive performance. Yet the supplement industry has focused almost exclusively on the waking hours, leaving the brain’s critical overnight recovery window largely unaddressed.

BioAdaptives, Inc. (OTC: BDPT) today announced the launch of MyndRenew™, a nighttime dietary supplement formulated to support sleep quality and the brain’s natural overnight recovery processes. MyndRenew™ is the nighttime component of the Company’s MyndSystem™ platform — a first-of-its-kind approach to cognitive support that spans the full 24-hour cycle.

Addressing the Overlooked Half of Cognitive Health

While the market has been saturated with morning stacks and daytime nootropics, the physiological processes that unfold during sleep — cellular repair, memory consolidation, metabolic waste clearance — have received comparatively little attention from supplement developers. MyndRenew™ was built to change that.

The formulation features 13 ingredients selected from published scientific literature, each included at levels consistent with those evaluated in clinical research. Together, they are intended to support multiple aspects of nighttime physiology:

  • Sleep quality and relaxation pathways
  • The brain’s natural overnight maintenance and recovery processes
  • Cellular resilience and mitochondrial energy function
  • Stress response regulation and nervous system balance
  • Antioxidant and neuroprotective activity

Key ingredients include magnesium glycinate, apigenin, PEA, and lion’s mane mushroom extract — anchor compounds with established research profiles in sleep quality, stress resilience, and neuroprotection, respectively.

Management Commentary

“We kept hearing from people who were doing everything right during the day — good nutrition, the right supplements, focused work habits — and still feeling mentally sluggish. The answer was often what wasn’t being supported at night. MyndRenew™ was built to close that gap.”

— James Keener, Chief Executive Officer, BioAdaptives, Inc.

The MyndSystem™ Platform: Full-Cycle Cognitive Support

MyndRenew™ joins MyndMed™ as the second pillar of the MyndSystem™ platform, which is designed to align with the brain’s distinct demands across the full daily cycle:

  • MyndMed™ — Daytime formulation designed to support focus, mental clarity, and cognitive endurance during waking hours
  • MyndRenew™ — Nighttime formulation designed to support sleep quality and the brain’s overnight recovery processes

Availability

MyndRenew™ is available now at www.myndsystem.com, alongside MyndMed™ and complete MyndSystem™ information. The Company also provides updates via X (formerly Twitter) at @BioAdaptivesInc.

About BioAdaptives, Inc.

BioAdaptives, Inc. develops and markets science-based health and wellness products for human and animal use. Its formulations are rooted in published research across nutrition, adaptogens, and cellular health, with a focus on supporting normal physiological function.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding product positioning, expected benefits, market opportunity, and future business strategy. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. BioAdaptives undertakes no obligation to update these statements except as required by law.

INVESTOR & MEDIA CONTACT

Emily Harrison
Investor Relations, BioAdaptives, Inc.
(702) 703-1233 | info@bioadaptives.com | www.bioadaptives.com
X – @BioAdaptivesInc

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.